Print this page

Mucosis’s mission is to discover and develop mucosal vaccines for the prevention and treatment of infectious diseases. It is our goal to transform excellent research into novel high-value vaccines which serve patients in need of an efficacious therapy and improved patient convenience.

Mucosis strives to discover innovative mucosal vaccines that are more efficacious and user-friendly by translating excellent scientific research into a robust vaccine technology which we use to create better, painless and needle-free vaccines to combat viral, bacterial and parasitic pathogens. We are dedicated to achieving these goals by motivating talented researchers to excel and by collaborating with the best academic and industrial partners in the world.


Mucosis B.V.
Meditech Center
L.J. Zielstraweg 1
9713 GX Groningen
The Netherlands